Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Serotonergic and catecholaminergic system in Alzheimer's disease (CROSBI ID 170206)

Prilog u časopisu | stručni rad

Muck-Šeler, Doroteja ; Mustapić, Maja ; Presečki, P. ; Mimica, N. ; Folnegović-Šmalc, Vera ; Pivac, Nela Serotonergic and catecholaminergic system in Alzheimer's disease // Periodicum biologorum. Supplement, 112 (2010), 1; 40-40

Podaci o odgovornosti

Muck-Šeler, Doroteja ; Mustapić, Maja ; Presečki, P. ; Mimica, N. ; Folnegović-Šmalc, Vera ; Pivac, Nela

engleski

Serotonergic and catecholaminergic system in Alzheimer's disease

Alzheimer's disease is a complex neurodegenerative disorder characterized with progressive memory loss, learning impairment and altered behavior. The most important risk factor for AD is aging. The role of the neurotransmitter systems in cognition and memory remains to be elucidated.The decrease in the brain and CSF concetration of serotonin (5-HT), noradrenaline and their metabolites, reduced brain 5-HT1A (raphe nuclei, hippocampus) and 5-HT2A (cerebral cortex) receptor binding, decreased 5-HT uptake into platelets and reduced platelet 5-HT concentration were found in patients with AD.

AD ; CSF ; 5-HT2A ; COMT ; DBH

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

112 (1)

2010.

40-40

objavljeno

0353-9164

Povezanost rada

Kliničke medicinske znanosti